Abstract
BackgroundTriple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and lacks definite treatment targets. Tumor immune microenvironment (TIME) heterogeneity has a profound impact on the immunotherapy response....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have